1994
Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1
Andiman W, Mezger J, Shapiro E. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. The Journal Of Pediatrics 1994, 124: 846-852. PMID: 8201465, DOI: 10.1016/s0022-3476(05)83169-5.Peer-Reviewed Original ResearchConceptsInvasive bacterial infectionsHuman immunodeficiency virus type 1Immunodeficiency virus type 1Years of ageVirus type 1Bacterial infectionsHIV-1 infection statusHIV-1-infected mothersHIV-1-infected patientsType 1Instances of bacteremiaSerious focal infectionsObservational cohort studyRate of infectionMonths of ageUninfected subjectsCohort studyPneumococcal bacteremiaInvasive infectionsFocal infectionHIV-1Cerebrospinal fluidS. pneumoniaeHIVStreptococcus pneumoniae
1985
Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
Kovatch A, Wald E, Albo V, Prin W, Orlando S, Wollman M, Phebus C, Shapiro E. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children. Pediatrics 1985, 76: 754-60. PMID: 3903647, DOI: 10.1542/peds.76.5.754.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAnti-Infective AgentsAntineoplastic AgentsBacterial InfectionsChildChild, PreschoolClinical Trials as TopicDouble-Blind MethodDrug CombinationsDrug Therapy, CombinationFemaleHumansInfantLeukemia, LymphoidLeukemia, Myeloid, AcuteMaleMicrobial Sensitivity TestsRandom AllocationSulfamethoxazoleTrimethoprimTrimethoprim, Sulfamethoxazole Drug CombinationConceptsTrimethoprim/sulfamethoxazoleOral trimethoprim/sulfamethoxazoleTrimethoprim/sulfamethoxazole groupFebrile episodesBacterial infectionsAcute leukemiaSolid tumorsPlacebo-controlled studyFrequency of bacteremiaInduction phaseInvasive fungal infectionsLife-table analysisGranulocytopenic childrenInduction chemotherapyReceiving placeboIntensive chemotherapyPlacebo groupOral thrushMean durationChemotherapyBacteremiaFungal infectionsOverall riskCancer chemotherapyInfection